Dopamine D3 receptor antagonist

This page covers all Dopamine D3 receptor antagonist drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Dopamine D3 receptor.

Targets

Dopamine D3 receptor

Phase 2 pipeline (1)

• BL 1020 High Dose · BioLineRx, Ltd. · Psychiatry
  BL 1020 is a dopamine D3 receptor antagonist that modulates dopaminergic signaling in the brain.

Patent intelligence

• dopamine d3 receptor antagonist patent landscape — aggregated cliff calendar, attackable patents, originator estates